← All stocks

MapLight Therapeutics, Inc.

MPLT Scheduled selling only

CIK 0001770069 #3078 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$192.66K

$192.66K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$192.66K

$0.00 against sales at will

By person

16 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hanson Kristopher

General Counsel

—

$192.66K (1) scheduled

−$192.66K

137,044

0.3229%

$1.60M

−25.2%

Catalyst4, Inc. entity

10% owner

—

25,306,689

59.63%

$295.33M

—

Novo Holdings A/S entity

10% owner

—

3,686,622

8.69%

$43.02M

—

Kroeger Christopher A.

Chief Executive Officer

—

1,269,600

2.99%

$14.82M

−20.7%

Setia Vishwas

Chief Financial Officer

—

356,256

0.8395%

$4.16M

−5.7%

Malenka Robert C.

Director

—

348,138

0.8204%

$4.06M

−11.4%

Foff Erin Pennock

Chief Medical Officer

—

312,261

0.7358%

$3.64M

−19.3%

Lillie James Woodruff

Chief Scientific Officer

—

210,110

0.4951%

$2.45M

−31.0%

Kreitzer Anatol

Chief Discovery Officer

—

180,926

0.4263%

$2.11M

−30.4%

GILLIS JONATHAN

CAO and Interim CFO

—

152,482

0.3593%

$1.78M

−36.5%

Garnett Timothy John

Director

—

67,581

0.1593%

$788.67K

+56.3%

Walker Maria C

Director

—

62,703

0.1478%

$731.74K

+19.5%

Pavlov George

Director

—

28,932

0.0682%

$337.64K

—

Cox Troy

Director

—

23,484

0.0553%

$274.06K

—

Babler Martin

Director

—

7,864

0.0185%

$91.77K

—

Luneborg Nanna Liebach

Director

—

3,932

0.0093%

$45.89K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 28 Oct 2025